Shiran Tehila Mashiah

Shiran Tehila Mashiah

Principal
💼 Partner at Peregrinevc →
About

Shiran Tehila Mashiah is a Principal at Peregrine Ventures and VP of Business Development for Incentive Incubator, specializing in Pharma and Biotech investments, a role she began in 2020. Beyond securing new investments, Ms. Mashiah plays an active strategic and governance role with portfolio companies, including serving as a Director for Lutris Pharma and as an Observer on the Board of Directors for entities such as KAHR Medical, Nectin Tx, and Ribon Therapeutics, while also interfacing closely with international strategic partners and investment committees. Prior to joining Peregrine, she was a senior biomed grant consultant at FreeMind, specializing in non-dilutive funding, where she developed and managed grant portfolios for biotech companies and led clinical trial–focused applications to agencies such as the NIH, DoD, NSF, and FDA. She holds an M.Sc. in Molecular Biology from the Weizmann Institute of Science and an MBA in Biomedical Business from The Hebrew University of Jerusalem.

Focus Areas

Pharma, BioTech

Location

📍 Based in Tel Aviv

Verified Contact & Outreach Agent

Direct Professional Email Pattern

[email protected] | [email protected]

AI Outreach Agent Pitch Writer

Compose an personalized, high-converting outreach message targeting their exact investment interest...

Unlock Direct Partner Outreach

View verified contact information and use our active Outreach Composer agent to draft custom intro pitches in seconds.

Connect via GRID to Outreach

100% free account · Get started in 1-click